Vertex: ball is in France’s court

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said it has tried six times to land on a reimbursement price with French authorities for its cystic fibrosis drug Orkambi ivacaftor/lumacaftor. Negotiations

Read the full 271 word article

User Sign In